These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 13766979)

  • 21. The prothrombin time in dicoumarol therapy.
    COLEMAN FC
    Ann Intern Med; 1949 May; 30(5):895-902. PubMed ID: 18126734
    [No Abstract]   [Full Text] [Related]  

  • 22. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 23. STUDIES ON PROCONVERTIN (FACTOR VII).V. BIOSYNTHESIS IN SUSPENSION CULTURES OF RAT LIVER CELLS.
    PRYDZ H
    Scand J Clin Lab Invest; 1964; 16():540-8. PubMed ID: 14209214
    [No Abstract]   [Full Text] [Related]  

  • 24. Absence of activity of estrogen and androgen hormones on the prothrombin complex of dogs treated with dicoumarol.
    ROSENFELD G; NAHAS L
    Acta Physiol Lat Am; 1961; 11():135-40. PubMed ID: 14493998
    [No Abstract]   [Full Text] [Related]  

  • 25. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.
    OWREN PA; AAS K
    Scand J Clin Lab Invest; 1951; 3(3):201-8. PubMed ID: 14900966
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the efficiency of vitamin K1 in small doses as antidote against anticoagulants of the dicoumarol type.
    GEILL T; LUND E; DAM H; SØNDERGAARD E
    Scand J Clin Lab Invest; 1954; 6(3):203-9. PubMed ID: 13205146
    [No Abstract]   [Full Text] [Related]  

  • 27. Variations in prothrombin and antithrombin following the administration of dicumarol.
    HURN M; BARKER NW; MANN FD
    Am J Clin Pathol; 1947 Sep; 17(9):712-8. PubMed ID: 20265749
    [No Abstract]   [Full Text] [Related]  

  • 28. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
    PUNDEL JP
    Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
    [No Abstract]   [Full Text] [Related]  

  • 29. Fate of dicumarol in man; relationship between prothrombin time and plasma levels of dicumarol.
    WEINER M; SHAPIRO S
    Bull N Y Acad Med; 1949 Jul; 25(7):449. PubMed ID: 18152257
    [No Abstract]   [Full Text] [Related]  

  • 30. Behaviour of factors II, VII, IX and X during long-term treatment with coumarin.
    LOELIGER EA; van der ESCH ; MATTERN MJ; den BRABANDER AS
    Thromb Diath Haemorrh; 1963 Apr; 9():74-89. PubMed ID: 13931274
    [No Abstract]   [Full Text] [Related]  

  • 31. The relationship of plasma prothrombin concentration and the degradation rate of serum "prothrombin-converting factor" during dicumarol therapy.
    JACOX RF; BAYS RF
    Blood; 1950 Apr; 5(4):313-19. PubMed ID: 15411419
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantitative determination of hirudin in blood and body fluids.
    Nowak G; Bucha E
    Semin Thromb Hemost; 1996; 22(2):197-202. PubMed ID: 8807717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dicumarol treatment in general practice].
    SCHWAN W
    Ther Ggw; 1952 Oct; 91(10):370-1. PubMed ID: 13029065
    [No Abstract]   [Full Text] [Related]  

  • 34. The significance of low prothrombin concentration prior to dicumarol therapy in myocardial infarction.
    PERRY TM; MILLER FN; RULLIS I
    Med Ann Dist Columbia; 1952 Jun; 21(6):303-6; passim. PubMed ID: 14940103
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of heparin on percentage content of prothrombin; range of variations and their significance in relation to heparin with dicumarol therapy].
    TAGLIACOZZO S
    Policlinico Chir; 1956; 63(3):141-59. PubMed ID: 13349502
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of tromexan and dicumarol on clotting time and prothrombin index].
    KRISTENSON A
    Nord Med; 1951 Jul; 46(29):1102-4. PubMed ID: 14863696
    [No Abstract]   [Full Text] [Related]  

  • 37. The complex mechanisms of the quick prothrombin test and the effect of dicumarol.
    MANN FD; HURN MM
    Am J Clin Pathol; 1950 Mar; 20(3):225-32. PubMed ID: 15432302
    [No Abstract]   [Full Text] [Related]  

  • 38. EFFECTS of dicumarol on prothrombin levels.
    Hosp Manage; 1950 Sep; 70(3):100. PubMed ID: 14773979
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimentally induced changes in the prothrombin level of the blood; quantitative studies in dogs given dicumarol; the effect of methylxanthines on prothrombin per se and when administered with dicumarol.
    QUICK AJ
    J Biol Chem; 1945; 161():33-44. PubMed ID: 21005712
    [No Abstract]   [Full Text] [Related]  

  • 40. [Variations in permeability, independent of variations in prothrombin time, produced by dicumarol].
    KUSCHINSKY G; LUDEWIG H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1950; 210(4-5):404-8. PubMed ID: 14777500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.